Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
1,390,020
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
282,070
-
Shares change
-
-156,819
-
Total reported value, excl. options
-
$894,000
-
Value change
-
-$561,407
-
Number of buys
-
3
-
Number of sells
-
6
-
Price
-
$3.17
Institutional Holders of Arcadia Biosciences, Inc. - Common Stock (RKDA) as of Q4 2018
As of 31 Dec 2018 Arcadia Biosciences, Inc. - Common Stock (RKDA) had 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 282,070 shares of stock of the company.
Largest 10 holders included SABBY MANAGEMENT, LLC, Anson Funds Management LP, BANK OF MONTREAL /CAN/, Virtu Financial LLC, DIMENSIONAL FUND ADVISORS LP, OXFORD ASSET MANAGEMENT LLP, Vanguard Group Inc, Advisor Group, Inc., SeaCrest Wealth Management, LLC, and BlackRock Inc..
This table shows 10 institutional shareholders of the security as of 31 Dec 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.